Teva Pharm Q3 beats estimates as acquisition lifts revenue

TEL AVIV, Nov 15 (Reuters) - Teva Pharmaceutical Industries

reported better than expected third-quarter profit as

sales were boosted by its $40.5 billion acquisition of

Allergan's generic drug...

Read more